Havens Advisors’s Celularity CELU Stock Holding History

Havens Advisors’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$202K	–	48
2021 Q1	$202K	Buy	+2,000	New	+$205K	0.18%	34

Other funds holding CELU

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Havens Advisors's CELU Position: Q2 2021 in Review

Havens Advisors sold out of Celularity (CELU) in Q2 2021, closing a stake of 2,000 shares — an estimated $202K sold.

Havens Advisors first reported a position in CELU in Q1 2021 and held it in 1 quarter. The position peaked at $202K in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

Havens Advisors reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
Havens Advisors sold 2,000 Celularity shares in Q2 2021, an estimated $202K.
Havens Advisors first reported a position in Celularity in Q1 2021 and held it in 1 quarter.
Havens Advisors's Celularity position peaked at $202K in Q1 2021.
33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Havens Advisors's 13F filing for Q2 2021, filed 14 Jul 2021.